Cutaneous T-cell lymphoma following dupilumab use: a systematic review. Park A, Wong L, Lang A, Kraus C, et al. Int J Dermatol 2022 Sep 8. doi: 10.1111/ijd.16388.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park A, Wong L, Lang A, Kraus C, et al. Cutaneous T-cell lymphoma following dupilumab use: a systematic review. Int J Dermatol 2022 Sep 8. doi: 10.1111/ijd.16388.
PMID: 36073768